Search filters

List of works by Ramón García-Sanz

6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis

scientific article published on 01 January 2007

A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients

scientific article published on 09 October 2019

A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma.

scientific article published on 15 November 2016

A RANDOMIZED PHASE 3 TRIAL OF ZANUBRUTINIB VERSUS IBRUTINIB IN SYMPTOMATIC WALDENSTRÖM MACROGLOBULINEMIA:THE ASPEN STUDY

scientific article published on 30 July 2020

A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.

scientific article published on 18 July 2016

A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America

scientific article published on 5 March 2018

A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

scientific article published on 17 May 2010

A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique

scientific article published on 01 December 1994

A new staging system for multiple myeloma based on the number of S-phase plasma cells

scientific article published on 01 January 1995

A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: biological and clinical utility

scientific article published on 15 March 2018

A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma

scientific article published on 30 July 2020

A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

scientific article published on 28 December 2019

A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma

scientific article published on 03 March 2015

A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia

scientific article published on 01 February 2000

A safety profile of medications used to treat Waldenström's macroglobulinemia.

scientific article

Absence of spontaneous response improvement beyond day +100 after autologous stem cell transplantation in multiple myeloma.

scientific article published on 21 November 2016

Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssion

scientific article published on 01 March 2001

Amiloride, An Old Diuretic Drug, Is a Potential Therapeutic Agent for Multiple Myeloma.

scientific article published on 8 August 2017

Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications

scientific article published in April 1996

Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.

scientific article

Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma

scientific article published on 17 February 2017

Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes.

scientific article published on 13 October 2016

Application of self-quenched JH consensus primers for real-time quantitative PCR of IGH gene to minimal residual disease evaluation in multiple myeloma.

scientific article

Are myeloma patients with renal failure candidates for autologous stem cell transplantation?

scientific article published on 01 January 2000

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design

scientific article published on 24 January 2020

Association of CD4 + /CD56 + /CD57 + /CD8 +dim large granular lymphocytic leukemia, splenic B-cell lymphoma with circulating villous lymphocytes, and idiopathic erythrocytosis

scientific article published on 01 November 2001

Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations

scientific article published on 09 August 2019

BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML).

scientific article published on 27 November 2009

BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years

scientific article published on 21 November 2016

BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors

scientific article published on 01 September 1997

Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma.

scientific article published on 2 May 2016

Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease

scientific article

Bisphosphonate-associated jaw osteonecrosis ⬇️

scientific article published on October 25, 2012

Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.

scientific article published on 22 April 2009

Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene

scientific article published on 7 December 2009

Bone remodelation markers are useful in the management of monoclonal gammopathies

scientific article published on 01 January 2004

Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy

scientific article

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

scientific article published on 13 June 2006

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression

scientific article published on 5 March 2008

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple m

scientific article published on 23 August 2010

Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group)

scientific article published on 01 April 2019

C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma

scientific article published on 07 April 2014

Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations

scientific article

Cell cycle analysis of Waldenstrom's macroglobulinemia

scientific article published on 01 March 2005

Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.

scientific article

Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance

scientific article published on 19 July 2013

Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting

scientific article published on 01 October 2008

Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study.

scientific article

Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival

scientific article published on 05 November 2020

Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin's lymphoma in patients older than 50 years

scientific article published on 18 October 2016

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

scientific article published on 30 October 2020

Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium

scientific article published on 13 February 2012

Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma (short title)

scientific article

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry.

scientific article published on 17 July 2013

Current Status of Cardio-Oncology in Spain: A National Multidisciplinary Survey

scientific article published in December 2017

Current functioning of cardio-oncology units in Spain

scientific article published on 20 December 2019

DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma

scientific article

DNA cell content studies in multiple myeloma

scientific article published on September 1996

De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis

scientific article published on January 2000

Debate round-table: comments concerning chimerism studies

scientific article published on 01 December 2001

Deletions and rearrangements of cyclin-dependent kinase 4 inhibitor gene p16 are associated with poor prognosis in B cell non-Hodgkin's lymphomas

scientific article published on 01 November 1997

Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.

scientific article published on 8 February 2018

Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.

scientific article

Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders.

scientific article published on 15 February 2016

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

scientific article published on December 2003

Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile

scientific article published on 26 September 2013

Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction

scientific article published on 01 November 2014

Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype

scientific article published on 01 March 1998

Differential diagnosis of IgM MGUS and WM according to B-lymphoid infiltration by morphology and flow cytometry

scientific article published on 01 February 2011

ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma

scientific article published on 27 May 2014

Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma

scientific article published in March 2004

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations.

scientific article published on 24 August 2012

Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma

scientific article

Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response.

scientific article

Evidence of long-term disease control with panobinostat maintenance in patients with relapsed multiple myeloma.

scientific article published on 20 March 2015

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

scientific article

Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma

scientific article published on 08 January 2019

Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia.

scientific article

Expression of the CD117 antigen (c-Kit) on normal and myelomatous plasma cells

scientific article published on 01 December 1996

Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients

scientific article published on 15 July 2021

FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor.

scientific article published in January 2004

Frequency of HLA-A, -B and -DRB1 specificities and haplotypic associations in the population of Castilla y León (northwest-central Spain).

scientific article published in October 2011

From Waldenström's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation

scientific article published on 25 August 2017

Functional class switch recombination may occur 'in vivo' in Waldenström macroglobulinaemia.

scientific article

Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

scientific article published on 01 October 2001

Genetic Variants and Multiple Myeloma Risk: IMMEnSE Validation of the Best Reported Associations--An Extensive Replication of the Associations from the Candidate Gene Era

article

Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristics

scientific article published on 01 May 2005

Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

article

Genetically determined telomere length and multiple myeloma risk and outcome

scientific article published on 14 April 2021

Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).

scientific article published on 06 December 2011

Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited RUNX1 mutations without a pre-existing platelet disorder

scientific article published on 06 August 2019

Genomic analysis of high-risk smoldering multiple myeloma.

scientific article published on 13 February 2012

Genomic evolution of ibrutinib-resistant clones in Waldenström macroglobulinaemia

scientific article published on 27 February 2020

HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis

scientific article

HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.

scientific article published on 10 July 2013

Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myeloma

scientific article published on 01 April 1999

Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies

scientific article published on 01 September 1999

High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics.

scientific article

High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.

scientific article published on 14 November 2015

Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism

scientific article published on 26 September 2006

Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.

scientific article

Identification of miRSNPs associated with the risk of multiple myeloma.

scientific article

Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

scientific article published on 17 June 2019

Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma.

scientific article published on 18 July 2007

Immunoglobulin lambda isotype gene rearrangements in B cell malignancies

scientific article published on 01 January 2001

Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression.

scientific article published on 11 March 2017

Immunophenotype and DNA cell content in multiple myeloma

scientific article published on December 1995

Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.

scientific article

Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma

scientific article

Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma

In vitro autonomous proliferation in ANLL: clinical and biological significance

scientific article published on 01 June 1995

Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR.

scientific article

Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications.

scientific article published in July 2003

Incomplete DJH rearrangements.

scientific article

Influence of biologic markers on the outcome of Hodgkin's lymphoma: a study by the Spanish Hodgkin's Lymphoma Study Group

scientific article published in May 2004

Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma

scientific article

Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse.

scientific article published on 2 November 2016

International Myeloma Working Group recommendations for global myeloma care

scientific article published on 09 October 2013

International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease

scientific article published on 20 May 2013

International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

scientific article published on 01 June 2019

International prognostic scoring system for Waldenstrom macroglobulinemia

scientific article published on 5 February 2009

Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms

scientific article published on 02 July 2013

Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma.

scientific article

Kikuchi-Fujimoto disease: a case supporting a role for human herpesvirus 7 involvement in the pathogenesis

scientific article published on 17 November 2012

Long-term reversibility of renal dysfunction associated to light chain deposition disease with bortezomib and dexamethasone and high dose therapy and autologous stem cell transplantation

scientific article published on September 2011

Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma.

scientific article published in April 2008

Low frequency of the TEL/AML1 fusion gene in acute lymphoblastic leukaemia in Spain

scientific article published on 01 December 1999

Lymphoma Heterogeneity: Three Different Histological Pictures and One Unique Clone

scientific article published on 27 October 2016

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.

scientific article

Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial

scientific article published on 13 August 2012

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma

scientific article published on 26 November 2019

Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival

scientific article published on 01 September 2002

Methylenetetrahydrofolate reductase genotype does not play a role in multiple myeloma pathogenesis.

scientific article

Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value.

scientific article

Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.

scientific article published in October 2005

Molecular biology of myeloma.

scientific article published on October 2007

Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma.

scientific article

Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: a different distribution in Central-West Spain

scientific article published in February 2001

Molecular characterization of complete and incomplete immunoglobulin heavy chain gene rearrangements in hairy cell leukemia

scientific article published on 01 November 2007

Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance

scientific article published on 01 May 2007

Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.

scientific article

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

scientific article published on 06 February 2020

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

scientific article

Monoclonal free light chains can be found in heavy chain diseases.

scientific article

Mujer de 74 años con dolor en la ingle derecha y osteólisis craneal

scientific article published on 01 April 2003

Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma

scientific article published on 29 May 2014

Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification

scientific article

Multiple Myeloma Minimal Residual Disease

scientific article

Multiple myeloma: treatment evolution

scientific article published on 01 April 2012

Multiple primary cutaneous plasmacytoma a decade after a nasal solitary extramedullary plasmacytoma: a puzzling case

scientific article published on 11 October 2016

Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing

scientific article published on 28 June 2018

Myeloma: Update on supportive care strategies ⬇️

scientific article published on June 1, 2003

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma.

scientific article published on 20 January 2017

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

scientific article published on 19 November 2018

Novel treatment regimens for Waldenström's macroglobulinemia

scientific article published on June 2010

Origin of Waldenstrom's macroglobulinaemia

scientific article published on June 2016

Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance

scientific article published on 6 September 2011

Pamidronate induces bone formation in patients with smouldering or indolent myeloma, with no significant anti-tumour effect

scientific article published in July 2002

Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities

article

Pegylated liposomal doxorubicin, melphalan and prednisone therapy for elderly patients with multiple myeloma

scientific article published in December 2006

Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial

scientific article published on 03 December 2020

Phase II clinical and pharmacokinetic study of plitidepsin 3-hour infusion every two weeks alone or with dexamethasone in relapsed and refractory multiple myeloma.

scientific article

Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.

scientific article

Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance

scientific article published on 11 January 2016

Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential

scientific article published on 12 November 2014

Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines

scientific article

Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium

scientific article published on 10 January 2013

Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case–control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium

scientific article published on 20 December 2011

Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma

scientific article published on 4 September 2015

Post-treatment bone marrow residual disease > 5% by flow cytometry is highly predictive of short progression-free and overall survival in patients with Waldenström's macroglobulinemia

scientific article published on 01 February 2011

Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936.

scientific article published on 14 December 2006

Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.

scientific article published on 8 September 2016

Primary cutaneous localized amyloid elastosis

scientific article published on 01 February 2010

Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics

scientific article published in February 1999

Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN).

scientific article published on 4 September 2013

Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients. Castelano-Leonés (Spain) Cooperative Group for the Study of Monoclonal Gammopathies

scientific article published on 01 May 1995

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

scientific article published in PLoS ONE

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

scientific article

Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes

scientific article published on 01 May 1998

Proliferative activity of plasma cells is the most relevant prognostic factor in elderly multiple myeloma patients

scientific article published on 01 December 2004

Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network

publication published on 06 September 2021

Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS

scientific article published on 21 June 2019

Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma

scientific article

Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma

scientific article published on 01 December 2020

RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation

scientific article published on 31 March 2022

Randomized comparison of dexamethasone combined with melphalan versus melphalan with prednisone in the treatment of elderly patients with multiple myeloma.

scientific article published in October 2004

Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.

scientific article

Recombinant human erythropoietin in the anaemia of multiple myeloma and non-Hodgkin's lymphoma

scientific article published on 01 August 1998

Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia

scientific article published on 05 July 2016

Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.

scientific article published on August 2007

Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma

scientific article

Relapse of multiple myeloma in extramedullary sites after autologous bone marrow transplantation

scientific article published on 01 March 1996

Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement

scientific article published on 01 July 2000

Reply to Brown et al: 'Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis'

scientific article published on 23 October 2019

Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop

scientific article

Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication

scientific article published on 25 October 2012

Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.

scientific article published on 6 August 2014

Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells

scientific article published on 11 October 2009

Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation

scientific article published in January 2006

SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status

scientific article published on 08 May 2012

Sequential intravenous-oral ciprofloxacin plus amoxycillin/clavulanic acid shortens hospital stay in infected non severe neutropenic patients

scientific article published on 01 October 1997

Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers

scientific article published on 01 January 2007

Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?

scientific article published on 7 December 2007

Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival

article

Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series

scientific article published on 31 January 2012

Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study

scientific article published on 26 June 2019

Status of methylation of p16 gene in multiple myeloma: a comparative study of three methods for its detection

scientific article published on 01 July 2000

Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation

scientific article published on 27 May 2010

Thalidomide in combination with cyclophosphamide and dexamethasone (thacydex) is effective in soft-tissue plasmacytomas.

scientific article published in December 2002

Thalidomide in multiple myeloma

scientific article published on 01 February 2006

The Progression from MGUS to Smoldering Myeloma and Eventually to Multiple Myeloma Involves a Clonal Expansion of Genetically Abnormal Plasma Cells

scientific article published on 16 February 2011

The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myeloma

scientific article published on 17 October 2006

The cellular origin and malignant transformation of Waldenström macroglobulinemia.

scientific article published on 5 February 2015

The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis

scientific article published on 25 January 2011

The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights

The combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is feasible and can be an option for relapsed/refractory multiple myeloma

scientific article

The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma

scientific article published on 12 November 2009

The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantation

scientific article published on 01 August 2000

The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements

scientific article published on 01 May 1999

The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy

scientific article published on 12 October 2016

The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma

scientific article published in April 2004

The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution.

scientific article

The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease

scientific article published on 07 April 2008

The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma.

scientific article published on 7 November 2014

The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.

scientific article

The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group

scientific article published on 02 September 2010

The whole dose at once?

scientific article published on 01 June 1996

Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.

scientific article

Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background

scientific article published on 20 November 2019

Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review

scientific article published on 01 July 2018

Treatment for patients with newly diagnosed multiple myeloma in 2015.

scientific article published on 12 June 2015

Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

scientific article

Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

scientific article published on 18 July 2016

Two new 3' PML breakpoints in t(15;17)(q22;q21)-positive acute promyelocytic leukemia

scientific article

Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium

scientific article published on 22 June 2015

Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study.

scientific article published on 20 January 2018

Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia

scientific article

Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia

scientific article published on December 2008

Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia

scientific article published on 12 January 2006

Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients

scientific article published on 15 December 2010

Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia

scientific article published on 01 March 2007

WM, MYD88, and CXCR4: following the thread

scientific article

Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases ⬇️

scientific article published on December 1, 2001

Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial

scientific article published on 11 June 2015

[Autologous transplant with BEAM protocol in lymphoma]

scientific article published on 01 April 1997

[Control of oral anticoagulant treatment using an automated method]

scientific article published on 01 April 1994

[Guidelines for the use of bisphosphonates in multiple myeloma: Recommendations of the expert committee of the Spanish Myeloma Group from the PETHEMA group]

scientific article published on 28 October 2009

[Molecular biology in malignant blood diseases. Clinical applications. Study of immunoglobulin and T-cell receptor genes and molecular analysis of the translocations]

scientific article published on 01 August 1996

[Molecular biology in malignant blood diseases. Methodological aspects: Southern blotting techniques and the polymerase chain reaction]

scientific article published on 01 August 1996

[Multiple myeloma]

scientific article published on 01 June 2007

[Primary amyloidosis]

scientific article published on 13 April 2016

[Value of serum free light chains assay in plasma cell disorders]

scientific article published on 03 July 2010

p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies

scientific article published on 01 January 2001

Paulina is supported by:

About Paulina

Help